SCHEMBL13638440

SCHEMBL13638440

C=C1CC(Nc2nccc(-c3ccc(O)cc3)n2)CC(C)(C)N1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
IKBKB O14920 11/20 0.43
MAPK8 P45983 3/20 0.39
HDAC8 Q9BY41 2/20 0.38
CDK4 P11802 3/20 0.37
CDK1 P06493 2/20 0.37
CCNB1 P14635 2/20 0.37
CCNA2 P20248 2/20 0.37
CCND1 P24385 2/20 0.37
CDK2 P24941 2/20 0.37
CCNA1 P78396 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
MAPK9 P45984 2/20 0.37
MAPK10 P53779 2/20 0.37
AURKA O14965 1/20 0.36
TTK P33981 1/20 0.36
AURKB Q96GD4 1/20 0.36
INCENP Q9NQS7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14612807 0.90 IKBKB (0.44) IKBKBMAPK8HDAC8CDK4CDK1
SCHEMBL14612849 0.90 IKBKB (0.35) IKBKBMAPK8HDAC8CDK4CDK1
SCHEMBL13638533 0.89 IKBKB (0.43) IKBKBMAPK8HDAC8CDK4CDK1
SCHEMBL13638678 0.89 IKBKB (0.42) IKBKBMAPK8HDAC8CDK4CDK1
SCHEMBL13638436 0.87 IKBKB (0.42) IKBKBMAPK8HDAC8CDK4CDK1
SCHEMBL14612854 0.87 IKBKB (0.42) IKBKBMAPK8HDAC8CDK4CDK1
SCHEMBL14612808 0.86 HDAC8 (0.44) IKBKBMAPK8HDAC8
SCHEMBL13638438 0.86 IKBKB (0.39) IKBKBMAPK8HDAC8CDK4CDK1
SCHEMBL13638592 0.85 IKBKB (0.41) IKBKBMAPK8HDAC8CDK4CDK1
SCHEMBL13638540 0.85 IKBKB (0.39) IKBKBMAPK8HDAC8MAPK9MAPK10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615562-B2 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents NOVARTIS AG (CH) 2009-11-10 US disclosed